Hanna Reynolds1, Sarah Steinfort1, Jane Tillyard1, Sarah Ellis1, Alan Hayes2,3,4, Erik D Hanson3,5, Tissa Wijeratne4,6, Elizabeth H Skinner7,8,9,10. 1. Department of Physiotherapy, Western Health, 176 Furlong Rd, St Albans, 3021, Australia. 2. Australian Institute of Musculoskeletal Science, Melbourne, Victoria, Australia. 3. The Institute for Health and Sport, Victoria University, Melbourne, Australia. 4. The University of Melbourne, Melbourne, Australia. 5. University of North Carolina, Chapel Hill, NC, USA. 6. Department of Neurology, Western Health, Melbourne, Australia. 7. Department of Physiotherapy, Western Health, 176 Furlong Rd, St Albans, 3021, Australia. elizabeth.skinner@wh.org.au. 8. Australian Institute of Musculoskeletal Science, Melbourne, Victoria, Australia. elizabeth.skinner@wh.org.au. 9. The University of Melbourne, Melbourne, Australia. elizabeth.skinner@wh.org.au. 10. Monash University, Melbourne, Victoria, Australia. elizabeth.skinner@wh.org.au.
Abstract
BACKGROUND:Stroke is a leading cause of disability worldwide and the cardiovascular fitness levels of stroke survivors are diminished to an extent that impairs functioning and activities of daily living performance. While cardiovascular training seems an empirically appropriate intervention, the optimal dosage and intensity of cardiovascular training in stroke survivors remains unclear. The aim was to determine the safety and feasibility of moderate-intensity cardiovascular training following stroke, including measurement of adherence to training. METHODS: A pilot, prospective, patient- and assessor-blinded randomised controlled trial conducted in a tertiary, metropolitan hospital-based community rehabilitation centre. Eligibility criteria included ambulant (> 100 m), 6 weeks-12 months post stroke. Moderate-intensity fitness training or control (low-intensity) exercise was offered biweekly for 12 weeks. Outcome measures included adverse events, peak oxygen uptake (VO2), functional exercise capacity (6-Minute Walk Test, 10-m Walk Test) and health-related quality of life (Short Form-36) and mood (Patient Health Questionnaire, PHQ9). RESULTS:Feasibility: Seventy-one (50%) of 141 screened participants were eligible (29% did not agree to participate). Twenty participants (10 intervention, 10 control) were recruited. The median (%; IQR) supervised sessions was 19.5 (81%; 12, 20); and 20 (83%; 19, 22) in the intervention and control groups, respectively. Progression of duration and intensity was limited; mean of 10 sessions to achieve target duration (30 min). There were no adverse events. Baseline peak oxygen uptake (VO2) levels were low (15.94 ml/kg/min). Significant improvements in VO2 peak in both groups were observed (p < 0.05). Although there were no significant between-group differences, this feasibility trial was not powered to detect change. CONCLUSIONS:Moderate-intensity fitness training was safe but achievement of target duration and intensity was challenging for stroke survivors. A definitive adequately-powered randomised trial is required. Alternative fitness training protocols may need to be explored. TRIAL REGISTRATION: The trial protocol was prospectively registered on the Australian New Zealand Clinical Trials Registry ( ACTRN 12613000822785 ) on 25/07/2013.
RCT Entities:
BACKGROUND:Stroke is a leading cause of disability worldwide and the cardiovascular fitness levels of stroke survivors are diminished to an extent that impairs functioning and activities of daily living performance. While cardiovascular training seems an empirically appropriate intervention, the optimal dosage and intensity of cardiovascular training in stroke survivors remains unclear. The aim was to determine the safety and feasibility of moderate-intensity cardiovascular training following stroke, including measurement of adherence to training. METHODS: A pilot, prospective, patient- and assessor-blinded randomised controlled trial conducted in a tertiary, metropolitan hospital-based community rehabilitation centre. Eligibility criteria included ambulant (> 100 m), 6 weeks-12 months post stroke. Moderate-intensity fitness training or control (low-intensity) exercise was offered biweekly for 12 weeks. Outcome measures included adverse events, peak oxygen uptake (VO2), functional exercise capacity (6-Minute Walk Test, 10-m Walk Test) and health-related quality of life (Short Form-36) and mood (Patient Health Questionnaire, PHQ9). RESULTS: Feasibility: Seventy-one (50%) of 141 screened participants were eligible (29% did not agree to participate). Twenty participants (10 intervention, 10 control) were recruited. The median (%; IQR) supervised sessions was 19.5 (81%; 12, 20); and 20 (83%; 19, 22) in the intervention and control groups, respectively. Progression of duration and intensity was limited; mean of 10 sessions to achieve target duration (30 min). There were no adverse events. Baseline peak oxygen uptake (VO2) levels were low (15.94 ml/kg/min). Significant improvements in VO2 peak in both groups were observed (p < 0.05). Although there were no significant between-group differences, this feasibility trial was not powered to detect change. CONCLUSIONS: Moderate-intensity fitness training was safe but achievement of target duration and intensity was challenging for stroke survivors. A definitive adequately-powered randomised trial is required. Alternative fitness training protocols may need to be explored. TRIAL REGISTRATION: The trial protocol was prospectively registered on the Australian New Zealand Clinical Trials Registry ( ACTRN 12613000822785 ) on 25/07/2013.
Authors: Debbie Hebert; M Patrice Lindsay; Amanda McIntyre; Adam Kirton; Peter G Rumney; Stephen Bagg; Mark Bayley; Dar Dowlatshahi; Sean Dukelow; Maridee Garnhum; Ev Glasser; Mary-Lou Halabi; Ester Kang; Marilyn MacKay-Lyons; Rosemary Martino; Annie Rochette; Sarah Rowe; Nancy Salbach; Brenda Semenko; Bridget Stack; Luchie Swinton; Valentine Weber; Matthew Mayer; Sue Verrilli; Gabrielle DeVeber; John Andersen; Karen Barlow; Caitlin Cassidy; Marie-Emmanuelle Dilenge; Darcy Fehlings; Ryan Hung; Jerome Iruthayarajah; Laura Lenz; Annette Majnemer; Jacqueline Purtzki; Mubeen Rafay; Lyn K Sonnenberg; Ashleigh Townley; Shannon Janzen; Norine Foley; Robert Teasell Journal: Int J Stroke Date: 2016-04-14 Impact factor: 5.266
Authors: Tammy C Hoffmann; Paul P Glasziou; Isabelle Boutron; Ruairidh Milne; Rafael Perera; David Moher; Douglas G Altman; Virginia Barbour; Helen Macdonald; Marie Johnston; Sarah E Lamb; Mary Dixon-Woods; Peter McCulloch; Jeremy C Wyatt; An-Wen Chan; Susan Michie Journal: BMJ Date: 2014-03-07
Authors: Sandra A Billinger; Ross Arena; Julie Bernhardt; Janice J Eng; Barry A Franklin; Cheryl Mortag Johnson; Marilyn MacKay-Lyons; Richard F Macko; Gillian E Mead; Elliot J Roth; Marianne Shaughnessy; Ada Tang Journal: Stroke Date: 2014-05-20 Impact factor: 7.914
Authors: Elizabeth H Skinner; Melanie Lloyd; Edward Janus; May Lea Ong; Amalia Karahalios; Terry P Haines; Anne-Maree Kelly; Melina Shackell; Harin Karunajeewa Journal: Trials Date: 2018-02-05 Impact factor: 2.279
Authors: Terry P Haines; Kelly-Ann Bowles; Deb Mitchell; Lisa O'Brien; Donna Markham; Samantha Plumb; Kerry May; Kathleen Philip; Romi Haas; Mitchell N Sarkies; Marcelle Ghaly; Melina Shackell; Timothy Chiu; Steven McPhail; Fiona McDermott; Elizabeth H Skinner Journal: PLoS Med Date: 2017-10-31 Impact factor: 11.069
Authors: Marilyn MacKay-Lyons; Gordon Gubitz; Stephen Phillips; Nicholas Giacomantonio; Wanda Firth; Kara Thompson; Chris Theriault; Howard Wightman; Sharon Slipp; David Marsters; Gail Eskes; Fiona Peacock; Chris Blanchard; Judy Dewolfe Journal: Neurorehabil Neural Repair Date: 2021-11-17 Impact factor: 3.919